ANI Pharmaceuticals, Inc. (ANIP)
Nasdaq: ANIP · Pharmaceutical Preparations · Baudette, MN · filing with the SEC since 1999
Grade6.3
◀ Past 6.3● Present 6.6▶ Future 5.8
Who runs ANI Pharmaceuticals, Inc.
Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filedChief executive, as filed
Lalwani Nikhil
PRESIDENT & CEO. First filing Sep 2020, latest Oct 16, 2026, 10 filings in all.
Officers reporting now
10
of 16 people with a filing in the last fifteen months
Directors reporting now
6
27 people on the record since 2006
Officerssales are open-market, Oct 30, 2025 to Oct 30, 2026
| Name | Title as filed | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Carey Stephen P. | SVP & CFO | May 2016 | Oct 30, 2026 | 9 · $2.2M |
| Lalwani Nikhil | PRESIDENT & CEO | Sep 2020 | Oct 16, 2026 | 4 · $5.4M |
| Cook Meredith | SR. VP, GENERAL COUNSEL & SEC. | Jul 2022 | Oct 13, 2026 | 12 · $500,000 |
| Gutwerg Ori | SVP, GENERICS | Feb 2021 | Aug 11, 2026 | 3 · $600,000 |
| Walsh Patrick D | CHAIRMAN, INTERIM PRES. & CEO | May 2018 | May 13, 2026 | 4 · $2.3M |
| Rowland Thomas Andrew | SVP, HEAD - ESTABLISHED BRANDS | Apr 2024 | May 13, 2026 | 2 · $400,000 |
| Mutz Christopher | HEAD OF RARE DISEASE | Feb 2021 | Mar 13, 2026 | 6 · $1.6M |
| Davis Krista | SVP, CHIEF HR OFFICER | Sep 2022 | Mar 10, 2026 | 5 · $900,000 |
| Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | Nov 2021 | Mar 2, 2026 | none |
| Gassert Chad | SVP - CORP. DEV. & STRATEGY | Nov 2021 | Mar 2, 2026 | 2 · $1.3M |
Directorssales are open-market, Oct 30, 2025 to Oct 30, 2026
| Name | Role | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Thoma Jeanne | director | Aug 2020 | Sep 14, 2026 | 1 · $100,000 |
| Gosebruch Henry O | director | Aug 2026 | Aug 27, 2026 | none |
| Haughey Thomas | director | May 2018 | Jun 10, 2026 | 1 · $200,000 |
| Leonard Matthew J | director | Aug 2023 | Jun 10, 2026 | none |
| Pera Antonio R | director | Aug 2020 | Jun 10, 2026 | none |
| Tannenbaum Renee P | director | Mar 2022 | Jun 10, 2026 | 1 · $100,000 |
Earlier names on the record14, newest filing first
Marken James G. · officer · last filing Jun 2024Brown Robert E. Jr · officer · last filing Aug 2023Meridian Venture Partners II Gp, L.P. · 10% owner · last filing Aug 2023Meridian Venture Partners II LP · 10% owner · last filing Aug 2023Meridian Venture Partners II, Co. · 10% owner · last filing Aug 2023Nash David · director · last filing May 2023Schrepfer Robert W · officer · last filing Mar 2021Przybyl Arthur · officer · last filing Apr 2020Penn Thomas A. · director · last filing Apr 2019Marshbanks Tracy · director · last filing May 2018Holubow Fred · director · last filing Mar 2018Raynor Daniel · director · last filing Mar 2018Arnold Charlotte C. · officer · last filing Apr 2016Lankau Peter A · director · last filing Apr 2016
A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.